Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Equity Ratio (2020 - 2025)

Treace Medical Concepts' Equity Ratio history spans 6 years, with the latest figure at 0.46 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 11.88% year-over-year to 0.46; the TTM value through Dec 2025 reached 0.46, down 11.88%, while the annual FY2025 figure was 0.46, 11.88% down from the prior year.
  • Equity Ratio reached 0.46 in Q4 2025 per TMCI's latest filing, up from 0.45 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.72 in Q2 2021 to a low of 0.02 in Q1 2021.
  • Average Equity Ratio over 5 years is 0.51, with a median of 0.52 recorded in 2024.
  • Peak YoY movement for Equity Ratio: soared 3460.77% in 2021, then tumbled 43.82% in 2022.
  • A 5-year view of Equity Ratio shows it stood at 0.66 in 2021, then tumbled by 42.41% to 0.38 in 2022, then surged by 43.86% to 0.55 in 2023, then decreased by 5.03% to 0.52 in 2024, then dropped by 11.88% to 0.46 in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Equity Ratio are 0.46 (Q4 2025), 0.45 (Q3 2025), and 0.47 (Q2 2025).